live attenuated Salmonella Typhi
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine strain
|
| gptkbp:administeredBy |
adults
oral vaccine children over 6 years |
| gptkbp:alternativeTo |
gptkb:Vi_polysaccharide_vaccine
|
| gptkbp:approvedBy |
gptkb:World_Health_Organization
|
| gptkbp:contains |
attenuated Salmonella Typhi bacteria
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:developedBy |
1970s
|
| gptkbp:duration |
5-7 years
|
| gptkbp:example |
Ty21a
|
| https://www.w3.org/2000/01/rdf-schema#label |
live attenuated Salmonella Typhi
|
| gptkbp:inducedBy |
immune response
|
| gptkbp:marketedAs |
gptkb:Vivotif
|
| gptkbp:mechanismOfAction |
stimulates mucosal immunity
|
| gptkbp:notRecommendedFor |
immunocompromised individuals
|
| gptkbp:requiresBooster |
yes
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
typhoid fever prevention
|
| gptkbp:usedIn |
endemic regions
|
| gptkbp:bfsParent |
gptkb:Ty21a_vaccine
|
| gptkbp:bfsLayer |
8
|